Anti-Counterfeit Pharmaceutical Packaging Market by Packaging Format (Bottles & Jars, Vials & Ampoules, Blisters, Trays, Pouches & Sachets), Technology (RFID, Security Inks & Coatings, Security Seals, Holograms, Mass Encryption, Barcode, Mass Serialization), and Region – Forecast 2022 – 2027– Between 2022 and 2027, the global anti-counterfeit pharmaceutical packaging market is predicted to rise at an annual rate of 8.4%. By 2027, it might be worth US$ 149.1 billion.
The global anti-counterfeit pharmaceutical packaging market is expected to increase significantly throughout the forecast period, according to the report’s findings, due to several driving factors. The anti-counterfeit pharmaceutical packaging market is expected to be worth US$ 99.6 billion in 2022, translating to a US$ 3.5 billion opportunity for anti-counterfeit technology for pharmaceuticals.
Competitive Landscape of the Global Anti-Counterfeit Pharmaceutical Packaging Market
Anti-counterfeit pharmaceutical packaging makers have made steps to combat the threat of counterfeit medications by developing new packaging techniques, which are still in their infancy but have a bright future. The demand for anti-counterfeit pharmaceutical packaging is likely to increase as technology advances.
RFID tags on the packaging of Viagra and Trizivir, an HIV treatment medicine, have been introduced by large pharmaceutical companies such as Pfizer and GlaxoSmithKline, which is boosting the anti-counterfeit pharmaceutical packaging industry growth.
This report highlights the major potential in the anti-counterfeit pharmaceutical packaging market, which is expected to develop at a CAGR of 8.4% over the forecast period.
Developing Economies Will Possess Promising Investment Prospects During the Forecast Period
China and Japan together account for more than half of the anti-counterfeit pharmaceutical packaging industry in Asia Pacific. This can be attributed to the fastest-growing pharmaceutical market, which is fueled by rising population and regulatory pressures in China and India’s pharmaceutical industries.
The anti-counterfeit pharmaceutical packaging market in the APAC region is being driven by a favorable industrial environment and a growing economy. Anti-counterfeit pharmaceutical packaging market expansion in the area is also fueled by the increasing penetration of local manufacturers in their respective regions.
Furthermore, during the projection period, rising Latin American economies such as Mexico and Argentina are likely to have promise in the anti-counterfeit pharmaceutical packaging market. Illegal prescription medication sales are becoming more common, especially in poor Latin American countries where a shortage of healthcare pushes individuals to seek cheaper alternatives.
This is stifling the expansion of the anti-counterfeit pharmaceutical packaging sector. The market for counterfeit medications and other medical goods has grown in the lack of an effective system and restrictions. Semi-legal duplication of branded pharmaceuticals by genuine local enterprises would also continue to be a high-profile issue. In the coming years, all of these variables will have an impact on the rise of anti-counterfeit pharmaceutical packaging.